The median annual TKV growth rate in this cohort was 4.27%, which was numerically lower than the predicted annual increase of 5.3%, although the difference did not reach statistical significance.
← all excerpts
Long-Term Effects of Tolvaptan Therapy on Total Kidney Volume and Renal Function in Patients with Autosomal Dominant Polycystic Kidney Disease: A Single-Center Experience.
1
—
—